Atlas Trials

Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma

Clinical trial NCT00669071 · TERMINATED

Trial details

NCT number
NCT00669071
Sponsor
Galderma R&D
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Melasma
Start date
2008-01-01
Primary completion
2008-10-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.